BNGO - Bionano Genomics, Inc.
3.69
-0.010 -0.271%
Share volume: 34,908
Last Updated: 05-07-2025
Measuring And Control Equipment/Lab Analytical Instruments:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$3.70
-0.01
0.00%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-08-2024 | 08-09-2023 | 11-08-2023 | 11-14-2024 | 05-08-2024 | 08-07-2024 | 11-14-2024 | |
Total revenue | 7.415 M | 8.662 M | 9.318 M | 10.721 M | 8.769 M | 7.771 M | 6.073 M | |
Cost of revenue | 5.345 M | 6.354 M | 6.569 M | 8.282 M | 5.945 M | 5.186 M | 14.519 M | |
Gross profit | 2.070 M | 2.308 M | 2.749 M | 2.439 M | 2.824 M | 2.585 M | -8.446 M | |
11.50% | 19.11% | -11.28% | 15.79% | -8.46% | -426.73% | |||
Operating expenses | 39.913 M | 41.546 M | 38.681 M | 27.391 M | 29.315 M | 18.388 M | 14.181 M | |
Selling general and admin | 25.976 M | 26.936 M | 24.896 M | 15.691 M | 19.536 M | 11.557 M | 9.464 M | |
Research and development | 13.937 M | 14.610 M | 13.785 M | 11.700 M | 9.779 M | 6.831 M | 4.717 M | |
Total expenses | 39.913 M | 41.546 M | 115.961 M | 27.391 M | 33.947 M | 19.603 M | 35.455 M | |
4.09% | 179.11% | -76.38% | 23.93% | -42.25% | 80.87% | |||
Operating income | -37.843 M | -39.238 M | -113.212 M | -24.952 M | -31.123 M | -17.018 M | -43.901 M | |
Ebit | -37.726 M | -39.568 M | -113.257 M | -40.143 M | -32.362 M | -16.655 M | -44.598 M | |
Pretax income | -37.098 M | -38.879 M | -112.527 M | -43.927 M | -31.440 M | -16.198 M | -44.222 M | |
4.80% | 189.43% | -60.96% | -28.43% | -48.48% | 173.01% | |||
Income tax | 26.000 K | 33.000 K | 39.000 K | -36.000 K | -18.000 K | 26.000 K | 24.000 K | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -37.124 M | -38.912 M | -112.566 M | -43.891 M | -31.422 M | -16.224 M | -44.246 M | |
-4.82% | -189.28% | 61.01% | 28.41% | 48.37% | -172.72% |